33
Participants
Start Date
December 13, 2023
Primary Completion Date
January 29, 2025
Study Completion Date
April 23, 2025
B/F/TAF
Tablets administered without regard to food
Bliss Health, Orlando
CHU Bordeaux - Hopital Saint-Andre, Bordeaux
Midway Immunology and Research Center, Ft. Pierce
CHR Orleans, Orléans
Indiana University Infectious Diseases Research, Indianapolis
Centre Hospitalier Annecy Genevois, Pringy
Las Vegas Research Center, Las Vegas
UC San Diego AntiViral Research Center (AVRC), San Diego
BIOS Clinical Research, Palm Springs
Franco Felizarta, MD, Bakersfield
MultiCare Rockwood Main Clinic, Spokane
Boston Medical Center, Boston
Saint Michael's Medical Center, Newark
Hamilton Health Sciences-SIS Clinic, Hamilton
St. Michael's Hospital, Toronto
University Health Network - Toronto General Hospital, Toronto
APHM - Hospital Sainte Marguerite, Marseille
HU de Strasbourg - Nouvel Hopital Civil, Strasbourg
Lead Sponsor
Gilead Sciences
INDUSTRY